ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane‐based chemotherapy

ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane‐based chemotherapy

Background Taxane‐based chemotherapy is widely used in lung cancer. ABCB1 have a role in the prediction of treatment response and toxicity of chemotherapy in solid tumors. In this retrospective study, we investigated ABCB1 polymorphism on response and toxicity in taxane‐based chemotherapy in lung ca...

Full description

Bibliographic Details
Main Authors: Jia Zhong, Zihan Guo, Liping Fan, Xinghui Zhao, Bingqing Zhao, Zhigang Cao, Linlin Cheng, Yuanyuan Shi, Xiaoting Li, Yanhua Zhang, Tongtong An, Meina Wu, Yuyan Wang, Minglei Zhuo, Jianjie Li, Xue Yang, Hanxiao Chen, Bo Jia, Jun Zhao
Format: Article
Language:English
Published: Wiley 2019-11-01
Series:Thoracic Cancer
Subjects:
ABCB1
chemotherapy
lung cancer
pharmacokinetic
Online Access:https://doi.org/10.1111/1759-7714.13184

Internet

https://doi.org/10.1111/1759-7714.13184

Similar Items